Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT-LANTUS: Insulin Glargine Titration Algorithms in Type 1 Diabetes
NCT00390728Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2002
- Primary completion
- Aug 2003
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Apr 2002; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00390728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390728.